DIG
PCRX icon

DeepCurrents Investment Group’s Pacira BioSciences PCRX Stock Holding History

DeepCurrents Investment Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,710
Closed -$741K – 239
2022
Q1 		$741K Buy
+9,710
New +$647K 0.02% 133

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DeepCurrents Investment Group's PCRX Position: Q2 2022 in Review

DeepCurrents Investment Group sold out of Pacira BioSciences (PCRX) in Q2 2022, closing a stake of 9,710 shares — an estimated $741K sold.

DeepCurrents Investment Group first reported a position in PCRX in Q1 2022 and held it in 1 quarter. The position peaked at $741K in Q1 2022. 284 funds tracked by Wall St. Rank hold PCRX as of Q2 2022.

  • DeepCurrents Investment Group reported no remaining Pacira BioSciences position as of Q2 2022 after selling out during the quarter.
  • DeepCurrents Investment Group sold 9,710 Pacira BioSciences shares in Q2 2022, an estimated $741K.
  • DeepCurrents Investment Group first reported a position in Pacira BioSciences in Q1 2022 and held it in 1 quarter.
  • DeepCurrents Investment Group's Pacira BioSciences position peaked at $741K in Q1 2022.
  • 284 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2022.

Based on DeepCurrents Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.